Filing Flows › Quest Diagnostics (DGX) › Q1 2026
Quest Diagnostics (DGX) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 22, 2026
Quest Diagnostics (DGX) reported revenue of $2.9B for the first quarter 2026 (Q1 2026), +9% from a year earlier and +3% from the quarter before. Operating margin was 13.8%, net earnings $252M (8.7% of revenue).
Quest Diagnostics, Q1 2026: revenue $2.9B (+9% year over year), operating margin 13.8%, net earnings $252M, operating cash flow $278M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9B | +3% | +9% |
| Operating profit | $399M | +3% | +15% |
| Net earnings | $252M | +3% | +15% |
| Operating cash flow | $278M | -40% | -11% |
| Free cash flow | $164M | -47% | -17% |
What changed
Revenue was $2.9B in Q1 2026, up 9% year over year and up 3% from the previous quarter. DIS business was the largest line at 98% of revenue. DIS business added $0.24B year over year (up 9%), 100% of the total change.
Operating profit was $0.40B, a 13.8% margin (up 0.7 points year over year). Of the extra revenue versus Q1 2025, 22% reached operating profit, above the 13% margin then. Total costs grew 8% against revenue growth of 9%. Net earnings were $0.25B, up 15% year over year. The effective tax rate was 21.9%.
Operating cash flow was $0.28B (down 11% year over year), 105% of net income including minority interests. Non-cash charges added back $0.15B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.15B. Capital expenditures of $0.11B left free cash flow of $0.16B.
Questions
What was Quest Diagnostics' revenue in the first quarter 2026?
Quest Diagnostics (DGX) reported revenue of $2.9B for the first quarter 2026 (Q1 2026), +9% from a year earlier and +3% from the quarter before.
Was Quest Diagnostics profitable in the first quarter 2026?
Operating profit was $399M (13.8% of revenue) and net earnings $252M.
Source: Quest Diagnostics 10-Q on SEC EDGAR.